IMMUCELL CORP /DE/ Logo

IMMUCELL CORP /DE/

Develops biotech health products for disease prevention in dairy and beef cattle.

ICCC | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
56 EVERGREEN DR, 4103 PORTLAND
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ImmuCell Corporation is an animal health biotechnology company that develops, manufactures, and markets scientifically-proven products to improve the health and productivity of dairy and beef cattle. The company's flagship product line, First Defense®, delivers 'Immediate Immunity™' to newborn calves, utilizing colostrum-derived antibodies to prevent scours caused by E. coli, coronavirus, and rotavirus. A key differentiator is ImmuCell's unique capability to concentrate, purify, and quantify these specific antibodies on a commercial scale. The company is also developing Re-Tain®, a nisin-based intramammary treatment for subclinical mastitis, as an alternative to traditional antibiotics. ImmuCell focuses on providing practical, cost-effective solutions for disease prevention, aiming to maximize genetic potential and reduce antibiotic reliance in the food chain.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IMMUCELL CORP /DE/ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUCELL CORP /DE/

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUCELL CORP /DE/ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.